Cizzle Brands Bringing CWENCH Hydration to Circle K Convenience Stores Across Ontario

Cizzle Brands Bringing CWENCH Hydration to Circle K Convenience Stores Across Ontario

CWENCH Hydration™ is now sold in 323 Circle K convenience stores across Ontario. As part of the rollout, Circle K will be providing merchandising and marketing support for CWENCH Hydration™ including dedicated in-store barrel coolers with CWENCH branding, as well as promotional campaigns advertising the availability of CWENCH Hydration™ beverages in its Ontario stores.

Cizzle Brands Corporation (Cboe Canada: CZZL) (OTCQB: CZZLF) (Frankfurt: 8YF) ( the "Company" or "Cizzle Brands") , is pleased to announce that CWENCH Hydration™ is now being sold in 323 Circle K convenience stores across the province of Ontario. The Circle K banner is owned by Alimentation Couche-Tard Inc. (" Couche-Tard "), a Canadian operator of convenience stores in 29 countries and territories which is publicly traded and is currently a component of the S&P/TSX 60 Index .

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250821549668/en/

CWENCH Hydration™ is now available at 323 Circle K locations across Ontario.

CWENCH Hydration™ is now available at 323 Circle K locations across Ontario.

Circle K is the latest multinational player in the consumer goods sector to carry CWENCH Hydration™, joining Keurig Dr Pepper Inc. subsidiary Van Houtte Coffee Services as announced in Cizzle Brands' January 29, 2025 press release.

The ready-to-drink format of the four original flavours of CWENCH Hydration™ ( Berry Crush , Cherry Lime , Blue Raspberry , and Rainbow Swirl ) are being merchandised in dedicated cooler barrels as well as sandwich cooler displays in Circle K stores, offering excellent visibility for the CWENCH Hydration™ brand, and an enhanced trial opportunity for first-time consumers of CWENCH. Circle K will also be promoting CWENCH Hydration™ as part of various campaigns, complementing Cizzle Brands' existing in-house marketing initiatives.

In addition, CWENCH Hydration™ will be available at Circle K's Frosh Week's activations at 15 universities across Canada from August 25 – September 13, 2025, reaching an anticipated 45,000 university students.

Couche-Tard operates more than 2,100 stores across Canada under its flagship Couche-Tard banner in Quebec and under the Circle K banner in all other Canadian markets, representing substantial upward potential for the CWENCH Hydration™ footprint to grow within Couche-Tard's far-reaching network in the Canadian retail landscape.

Cizzle Brands' Founder, Chairman, and Chief Executive Officer John Celenza commented, "Building on the momentum for CWENCH Hydration™ as we enter its second year on the market, we are thrilled to have landed this deal with one of the top global names in convenience. Now that we've achieved initial market penetration in specialty retail in several hand-picked North American regions, we are making CWENCH Hydration™ available to consumers at a much broader scale by partnering with Circle K, a national convenience banner. This is the next step in making CWENCH a true household name. We are grateful for the promotional and marketing support that Circle K will be providing, which will make the coming seasons very exciting and productive for us as we continue to drive long-term growth for the CWENCH Hydration™ brand."

About Cizzle Brands Corporation

Cizzle Brands Corporation is a sports nutrition company that is elevating the game in health and wellness. Through extensive collaboration and testing with leading athletes and trainers across several elite sports, Cizzle Brands has launched two leading product lines in the sports nutrition category: (i) CWENCH Hydration™, a better-for-you sports drink that is now carried in over 4,400 locations in Canada, the United States, and Europe; and (ii) Spoken Nutrition, a premium brand of athlete-grade nutraceuticals that carry the prestigious NSF Certified for Sport® qualification. All Cizzle Brands products are designed to help people achieve their best in both competitive sports and in living a healthy, vibrant, active lifestyle.

For more information about Cizzle Brands, please visit: https://www.cizzlebrands.com/

For more information about CWENCH Hydration™, please visit: https://www.cwenchhydration.com

On behalf of the Board of Directors of the Company,

Cizzle Brands Corporation

"John Celenza"

John Celenza, Founder, Chairman, and Chief Executive Officer

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" which may include, but is not limited to, information with respect to the activities, events or developments that the Company expects or anticipates will or may occur in the future, such as, but not limited to: new products of the Company and potential sales and distribution opportunities. Such forward-looking information is often, but not always, identified by the use of words and phrases such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the Company.

Forward looking information involves known and unknown risks, uncertainties and other risk factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such risks include risks related to increased competition and current global financial conditions, access and supply risks, reliance on key personnel, operational risks, regulatory risks, financing, capitalization and liquidity risks. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company undertakes no obligation, except as otherwise required by law, to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors change.

Setti Coscarella
Head of Corporate Development
investors@cizzlebrands.com
1-844-588-2088

News Provided by Business Wire via QuoteMedia

CZZL:AQL
The Conversation (0)
Cizzle Brands Corporation (CBOE:CZZL)

Cizzle Brands Corporation

A Sports Nutrition Company Leading the Next Wave in Health and Wellness

A Sports Nutrition Company Leading the Next Wave in Health and Wellness Keep Reading...
Seegnal Inc

Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

Seegnal Inc. (TSXV: SEGN), a global leader in clinical decision support solutions applying patient-centric medication safety standards, today announced its deepened partnership with Tel Aviv Sourasky Medical Center ("Sourasky Medical Center"). Israel's second-largest public hospital, Sourasky... Keep Reading...
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced that it has closed its previously announced private... Keep Reading...
Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced that it has entered into an agreement with a sole... Keep Reading...
Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced that it has entered into an agreement with Canaccord... Keep Reading...
Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers actively enrolling patients.Activation of additional top-tier clinical sites in Europe and Canada underway, further accelerating enrollment momentum.Full enrollment expected in Q2... Keep Reading...
Group of male and female scientists working in laboratory.

Inside the ASX Biotech Boom: What’s Fuelling the Next Wave

Australia’s healthcare and biotechnology sector has matured into one of the most promising and strategically important segments of the ASX. Fortunes can shift on a single clinical trial result. A company with no revenue today could be a global contender tomorrow — if its science holds up. As... Keep Reading...

Interactive Chart

Latest Press Releases

Related News